Beljkas, M.; Ilic, A.; Cebzan, A.; Radovic, B.; Djokovic, N.; Ruzic, D.; Nikolic, K.; Oljacic, S.
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics 2023, 15, 2581.
https://doi.org/10.3390/pharmaceutics15112581
AMA Style
Beljkas M, Ilic A, Cebzan A, Radovic B, Djokovic N, Ruzic D, Nikolic K, Oljacic S.
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics. 2023; 15(11):2581.
https://doi.org/10.3390/pharmaceutics15112581
Chicago/Turabian Style
Beljkas, Milan, Aleksandra Ilic, Alen Cebzan, Branko Radovic, Nemanja Djokovic, Dusan Ruzic, Katarina Nikolic, and Slavica Oljacic.
2023. "Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer" Pharmaceutics 15, no. 11: 2581.
https://doi.org/10.3390/pharmaceutics15112581
APA Style
Beljkas, M., Ilic, A., Cebzan, A., Radovic, B., Djokovic, N., Ruzic, D., Nikolic, K., & Oljacic, S.
(2023). Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics, 15(11), 2581.
https://doi.org/10.3390/pharmaceutics15112581